19 results on '"Maillart, Elisabeth"'
Search Results
2. Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases
3. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies
4. Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGADin Adults: The MOGADOR2 Study.
5. Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
6. Frequent detection of IFN-gamma-producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy.
7. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
8. Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.
9. Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.
10. High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
11. Longitudinally extensive posterolateral myelitis revealing invasive CNS aspergillosis in an immunocompetent patient.
12. Impact of ImmuneCheckpoint Inhibitors on theCourse of Multiple Sclerosis.
13. Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
14. COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
15. The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years—Protocol, recruitment status, and baseline characteristics.
16. Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
17. Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks.
18. Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?
19. Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.